SA
IGC logo
IGC Pharma, Inc.(IGC)
Closing price · checked 9:40 PM ETAbout this dataData status
$0.17▼-0.02 (-8.70%)
Extended:$0.17+0.00 (+1.19%)· 9:40 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Consensus

Buy4.00 / 51 rating · Buy 1

Price vs analyst targets

Revenue and EPS estimates

ReportedConsensus estimates
Fiscal periodFY2024Mar '24FY2025Mar '25FY2026Mar '26FY2027Mar '27FY2028Mar '28
Revenue (M)1.31.21.10.90.9
Growth YoY+47.5%−10.7%−9.9%−20.8%0.0%
High estimate–––0.90.9
Low estimate–––0.90.9
Analysts–––11
EPS, adjusted−0.26−0.09−0.08−0.09−0.08
Growth YoYn/mn/mn/mn/mn/m
High estimate–––−0.09−0.08
Low estimate–––−0.09−0.08
Analysts–––11

Consensus mean of analyst estimates. EPS is adjusted (street) EPS, the basis analysts forecast; annual actuals are the sum of the four reported quarters. Growth compares with the same period a year earlier; n/m where the prior period was a loss.

Brokers

1 firms active in the last 12 months
FirmAnalystRatingPrev ratingTargetPrev targetChgUpsideDate
Ascendiant Capital–BuyBuy––––Aug 26

Latest analyst action Page refreshed hourly; analyst feeds refreshed dailyAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.